Global Topical Corticosteroids Market 2023-2027
The topical corticosteroids market is forecasted to grow by USD 1,089.66 mn during 2022-2027, accelerating at a CAGR of 4% during the forecast period. The report on the topical corticosteroids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in drug delivery systems, the growing aging population, and the rising prevalence of skin disorders.
Technavio's topical corticosteroids market is segmented as below:
By End-user
- Hospitals
- Dermatology clinics
- Pharmacies
- Others
- Prescription
- OTC
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the topical corticosteroids market covers the following areas:
- Topical corticosteroids market sizing
- Topical corticosteroids market forecast
- Topical corticosteroids market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
- 1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
- 2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
- 3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
- 4 Historic Market Size
- 4.1 Global topical corticosteroids market 2017 - 2021
- Exhibit 18: Historic Market Size - Data Table on global topical corticosteroids market 2017 - 2021 ($ million)
- 4.2 End-user Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
- 4.3 Type Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
- 5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
- 6 Market Segmentation by End-user
- 6.1 Market segments
- Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
- 6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user
- 6.3 Hospitals - Market size and forecast 2022-2027
- Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
- 6.4 Dermatology clinics - Market size and forecast 2022-2027
- Exhibit 38: Chart on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Dermatology clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Dermatology clinics - Year-over-year growth 2022-2027 (%)
- 6.5 Pharmacies - Market size and forecast 2022-2027
- Exhibit 42: Chart on Pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
- 6.6 Others - Market size and forecast 2022-2027
- Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 6.7 Market opportunity by End-user
- Exhibit 50: Market opportunity by End-user ($ million)
- Exhibit 51: Data Table on Market opportunity by End-user ($ million)
- 7 Market Segmentation by Type
- 7.1 Market segments
- Exhibit 52: Chart on Type - Market share 2022-2027 (%)
- Exhibit 53: Data Table on Type - Market share 2022-2027 (%)
- 7.2 Comparison by Type
- Exhibit 54: Chart on Comparison by Type
- Exhibit 55: Data Table on Comparison by Type
- 7.3 Prescription - Market size and forecast 2022-2027
- Exhibit 56: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Prescription - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
- 7.4 OTC - Market size and forecast 2022-2027
- Exhibit 60: Chart on OTC - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Data Table on OTC - Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Chart on OTC - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on OTC - Year-over-year growth 2022-2027 (%)
- 7.5 Market opportunity by Type
- Exhibit 64: Market opportunity by Type ($ million)
- Exhibit 65: Data Table on Market opportunity by Type ($ million)
- 8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
- Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Russia - Market size and forecast 2022-2027
- Exhibit 91: Chart on Russia - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Russia - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Russia - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Russia - Year-over-year growth 2022-2027 (%)
- 9.9 Saudi Arabia - Market size and forecast 2022-2027
- Exhibit 95: Chart on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Saudi Arabia - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Saudi Arabia - Year-over-year growth 2022-2027 (%)
- 9.10 Canada - Market size and forecast 2022-2027
- Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
- 9.11 China - Market size and forecast 2022-2027
- Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity By Geographical Landscape
- Exhibit 107: Market opportunity By Geographical Landscape ($ million)
- Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
- 10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
- 11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 112: Impact of key risks on business
- 12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 113: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification
- 12.3 AbbVie Inc.
- Exhibit 115: AbbVie Inc. - Overview
- Exhibit 116: AbbVie Inc. - Product / Service
- Exhibit 117: AbbVie Inc. - Key news
- Exhibit 118: AbbVie Inc. - Key offerings
- 12.4 Astellas Pharma Inc.
- Exhibit 119: Astellas Pharma Inc. - Overview
- Exhibit 120: Astellas Pharma Inc. - Product / Service
- Exhibit 121: Astellas Pharma Inc. - Key news
- Exhibit 122: Astellas Pharma Inc. - Key offerings
- 12.5 AstraZeneca PLC
- Exhibit 123: AstraZeneca PLC - Overview
- Exhibit 124: AstraZeneca PLC - Product / Service
- Exhibit 125: AstraZeneca PLC - Key news
- Exhibit 126: AstraZeneca PLC - Key offerings
- 12.6 Bausch Health Co. Inc.
- Exhibit 127: Bausch Health Co. Inc. - Overview
- Exhibit 128: Bausch Health Co. Inc. - Business segments
- Exhibit 129: Bausch Health Co. Inc. - Key news
- Exhibit 130: Bausch Health Co. Inc. - Key offerings
- Exhibit 131: Bausch Health Co. Inc. - Segment focus
- 12.7 Bayer AG
- Exhibit 132: Bayer AG - Overview
- Exhibit 133: Bayer AG - Business segments
- Exhibit 134: Bayer AG - Key news
- Exhibit 135: Bayer AG - Key offerings
- Exhibit 136: Bayer AG - Segment focus
- 12.8 Eli Lilly and Co.
- Exhibit 137: Eli Lilly and Co. - Overview
- Exhibit 138: Eli Lilly and Co. - Product / Service
- Exhibit 139: Eli Lilly and Co. - Key news
- Exhibit 140: Eli Lilly and Co. - Key offerings
- 12.9 Galderma SA
- Exhibit 141: Galderma SA - Overview
- Exhibit 142: Galderma SA - Product / Service
- Exhibit 143: Galderma SA - Key news
- Exhibit 144: Galderma SA - Key offerings
- 12.10 GlaxoSmithKline Plc
- Exhibit 145: GlaxoSmithKline Plc - Overview
- Exhibit 146: GlaxoSmithKline Plc - Business segments
- Exhibit 147: GlaxoSmithKline Plc - Key news
- Exhibit 148: GlaxoSmithKline Plc - Key offerings
- Exhibit 149: GlaxoSmithKline Plc - Segment focus
- 12.11 Glenmark Pharmaceuticals Ltd.
- Exhibit 150: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibit 151: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibit 152: Glenmark Pharmaceuticals Ltd. - Key offerings
- 12.12 LEO Pharma AS
- Exhibit 153: LEO Pharma AS - Overview
- Exhibit 154: LEO Pharma AS - Business segments
- Exhibit 155: LEO Pharma AS - Key offerings
- Exhibit 156: LEO Pharma AS - Segment focus
- 12.13 Merck and Co. Inc.
- Exhibit 157: Merck and Co. Inc. - Overview
- Exhibit 158: Merck and Co. Inc. - Business segments
- Exhibit 159: Merck and Co. Inc. - Key news
- Exhibit 160: Merck and Co. Inc. - Key offerings
- Exhibit 161: Merck and Co. Inc. - Segment focus
- 12.14 Novartis AG
- Exhibit 162: Novartis AG - Overview
- Exhibit 163: Novartis AG - Business segments
- Exhibit 164: Novartis AG - Key offerings
- Exhibit 165: Novartis AG - Segment focus
- 12.15 Pfizer Inc.
- Exhibit 166: Pfizer Inc. - Overview
- Exhibit 167: Pfizer Inc. - Product / Service
- Exhibit 168: Pfizer Inc. - Key news
- Exhibit 169: Pfizer Inc. - Key offerings
- 12.16 Sanofi SA
- Exhibit 170: Sanofi SA - Overview
- Exhibit 171: Sanofi SA - Business segments
- Exhibit 172: Sanofi SA - Key news
- Exhibit 173: Sanofi SA - Key offerings
- Exhibit 174: Sanofi SA - Segment focus
- 12.17 Viatris Inc.
- Exhibit 175: Viatris Inc. - Overview
- Exhibit 176: Viatris Inc. - Business segments
- Exhibit 177: Viatris Inc. - Key news
- Exhibit 178: Viatris Inc. - Key offerings
- Exhibit 179: Viatris Inc. - Segment focus
- 13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 180: Inclusions checklist
- Exhibit 181: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 182: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 183: Research methodology
- Exhibit 184: Validation techniques employed for market sizing
- Exhibit 185: Information sources
- 13.5 List of abbreviations
- Exhibit 186: List of abbreviations
- Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
- Exhibits6: Executive Summary - Chart on Market Segmentation by Type
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Vendor Market Positioning
- Exhibits10: Parent market
- Exhibits11: Market Characteristics
- Exhibits12: Offerings of vendors included in the market definition
- Exhibits13: Market segments
- Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibits18: Historic Market Size - Data Table on global topical corticosteroids market 2017 - 2021 ($ million)
- Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
- Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
- Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
- Exhibits23: Five forces analysis - Comparison between 2022 and 2027
- Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
- Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
- Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
- Exhibits29: Chart on Market condition - Five forces 2022 and 2027
- Exhibits30: Chart on End-user - Market share 2022-2027 (%)
- Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
- Exhibits32: Chart on Comparison by End-user
- Exhibits33: Data Table on Comparison by End-user
- Exhibits34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibits35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibits36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibits37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibits38: Chart on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
- Exhibits39: Data Table on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
- Exhibits40: Chart on Dermatology clinics - Year-over-year growth 2022-2027 (%)
- Exhibits41: Data Table on Dermatology clinics - Year-over-year growth 2022-2027 (%)
- Exhibits42: Chart on Pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibits43: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ million)
- Exhibits44: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
- Exhibits45: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
- Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
- Exhibits50: Market opportunity by End-user ($ million)
- Exhibits51: Data Table on Market opportunity by End-user ($ million)
- Exhibits52: Chart on Type - Market share 2022-2027 (%)
- Exhibits53: Data Table on Type - Market share 2022-2027 (%)
- Exhibits54: Chart on Comparison by Type
- Exhibits55: Data Table on Comparison by Type
- Exhibits56: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
- Exhibits57: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
- Exhibits58: Chart on Prescription - Year-over-year growth 2022-2027 (%)
- Exhibits59: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
- Exhibits60: Chart on OTC - Market size and forecast 2022-2027 ($ million)
- Exhibits61: Data Table on OTC - Market size and forecast 2022-2027 ($ million)
- Exhibits62: Chart on OTC - Year-over-year growth 2022-2027 (%)
- Exhibits63: Data Table on OTC - Year-over-year growth 2022-2027 (%)
- Exhibits64: Market opportunity by Type ($ million)
- Exhibits65: Data Table on Market opportunity by Type ($ million)
- Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
- Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
- Exhibits69: Chart on Geographic comparison
- Exhibits70: Data Table on Geographic comparison
- Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
- Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
- Exhibits91: Chart on Russia - Market size and forecast 2022-2027 ($ million)
- Exhibits92: Data Table on Russia - Market size and forecast 2022-2027 ($ million)
- Exhibits93: Chart on Russia - Year-over-year growth 2022-2027 (%)
- Exhibits94: Data Table on Russia - Year-over-year growth 2022-2027 (%)
- Exhibits95: Chart on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
- Exhibits96: Data Table on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
- Exhibits97: Chart on Saudi Arabia - Year-over-year growth 2022-2027 (%)
- Exhibits98: Data Table on Saudi Arabia - Year-over-year growth 2022-2027 (%)
- Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
- Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
- Exhibits107: Market opportunity By Geographical Landscape ($ million)
- Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
- Exhibits109: Impact of drivers and challenges in 2022 and 2027
- Exhibits110: Overview on Criticality of inputs and Factors of differentiation
- Exhibits111: Overview on factors of disruption
- Exhibits112: Impact of key risks on business
- Exhibits113: Vendors covered
- Exhibits114: Matrix on vendor position and classification
- Exhibits115: AbbVie Inc. - Overview
- Exhibits116: AbbVie Inc. - Product / Service
- Exhibits117: AbbVie Inc. - Key news
- Exhibits118: AbbVie Inc. - Key offerings
- Exhibits119: Astellas Pharma Inc. - Overview
- Exhibits120: Astellas Pharma Inc. - Product / Service
- Exhibits121: Astellas Pharma Inc. - Key news
- Exhibits122: Astellas Pharma Inc. - Key offerings
- Exhibits123: AstraZeneca PLC - Overview
- Exhibits124: AstraZeneca PLC - Product / Service
- Exhibits125: AstraZeneca PLC - Key news
- Exhibits126: AstraZeneca PLC - Key offerings
- Exhibits127: Bausch Health Co. Inc. - Overview
- Exhibits128: Bausch Health Co. Inc. - Business segments
- Exhibits129: Bausch Health Co. Inc. - Key news
- Exhibits130: Bausch Health Co. Inc. - Key offerings
- Exhibits131: Bausch Health Co. Inc. - Segment focus
- Exhibits132: Bayer AG - Overview
- Exhibits133: Bayer AG - Business segments
- Exhibits134: Bayer AG - Key news
- Exhibits135: Bayer AG - Key offerings
- Exhibits136: Bayer AG - Segment focus
- Exhibits137: Eli Lilly and Co. - Overview
- Exhibits138: Eli Lilly and Co. - Product / Service
- Exhibits139: Eli Lilly and Co. - Key news
- Exhibits140: Eli Lilly and Co. - Key offerings
- Exhibits141: Galderma SA - Overview
- Exhibits142: Galderma SA - Product / Service
- Exhibits143: Galderma SA - Key news
- Exhibits144: Galderma SA - Key offerings
- Exhibits145: GlaxoSmithKline Plc - Overview
- Exhibits146: GlaxoSmithKline Plc - Business segments
- Exhibits147: GlaxoSmithKline Plc - Key news
- Exhibits148: GlaxoSmithKline Plc - Key offerings
- Exhibits149: GlaxoSmithKline Plc - Segment focus
- Exhibits150: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibits151: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibits152: Glenmark Pharmaceuticals Ltd. - Key offerings
- Exhibits153: LEO Pharma AS - Overview
- Exhibits154: LEO Pharma AS - Business segments
- Exhibits155: LEO Pharma AS - Key offerings
- Exhibits156: LEO Pharma AS - Segment focus
- Exhibits157: Merck and Co. Inc. - Overview
- Exhibits158: Merck and Co. Inc. - Business segments
- Exhibits159: Merck and Co. Inc. - Key news
- Exhibits160: Merck and Co. Inc. - Key offerings
- Exhibits161: Merck and Co. Inc. - Segment focus
- Exhibits162: Novartis AG - Overview
- Exhibits163: Novartis AG - Business segments
- Exhibits164: Novartis AG - Key offerings
- Exhibits165: Novartis AG - Segment focus
- Exhibits166: Pfizer Inc. - Overview
- Exhibits167: Pfizer Inc. - Product / Service
- Exhibits168: Pfizer Inc. - Key news
- Exhibits169: Pfizer Inc. - Key offerings
- Exhibits170: Sanofi SA - Overview
- Exhibits171: Sanofi SA - Business segments
- Exhibits172: Sanofi SA - Key news
- Exhibits173: Sanofi SA - Key offerings
- Exhibits174: Sanofi SA - Segment focus
- Exhibits175: Viatris Inc. - Overview
- Exhibits176: Viatris Inc. - Business segments
- Exhibits177: Viatris Inc. - Key news
- Exhibits178: Viatris Inc. - Key offerings
- Exhibits179: Viatris Inc. - Segment focus
- Exhibits180: Inclusions checklist
- Exhibits181: Exclusions checklist
- Exhibits182: Currency conversion rates for US$
- Exhibits183: Research methodology
- Exhibits184: Validation techniques employed for market sizing
- Exhibits185: Information sources
- Exhibits186: List of abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook